Molecular Oncology Diagnostics, An Issue of the Clinics in Laboratory Medicine

— —

Fei Dong, MD (Associate Pathologist , Brigham and Women's Hospital , Assistant Professor , Harvard Medical School)

Molecular Oncology Diagnostics, An Issue of the Clinics in Laboratory Medicine

Fei Dong, MD (Associate Pathologist , Brigham and Women's Hospital , Assistant Professor , Harvard Medical School)

$158.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Elsevier - Health Sciences Division
23 September 2022

Medical laboratory testing & techniques; Oncology; Pathology

Series: Clinics Review Articles: Laboratory Medicine

In this issue of Clinics in Laboratory Medicine, guest editor Dr. Fei Dong brings his considerable expertise to the topic of Molecular Oncology Diagnostics. Top experts in the field review current practices in molecular oncology diagnostics, highlighting the rapid clinical adoption of next generation sequencing techniques. The articles address key laboratory considerations in the molecular testing of cancer specimens and the impact of advanced testing strategies on patient care.

Contains 15 practice-oriented topics including utility of single gene testing in cancer specimens; analytical principles of cancer next generation sequencing; principles and validation of bioinformatics pipelines for cancer next generation sequencing; panel sequencing for targeted therapy selection in solid tumors; and more.

Provides in-depth clinical reviews on molecular oncology diagnostics, offering actionable insights for clinical practice.

Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Edited by: Fei Dong MD (Associate Pathologist Brigham and Women's Hospital Assistant Professor Harvard Medical School)
Imprint: Elsevier - Health Sciences Division
Country of Publication: United States
Weight: 4.120kg
ISBN: 9780323849364
ISBN 10: 0323849369
Series: Clinics Review Articles: Laboratory Medicine
Pages: 240
Publication Date: 23 September 2022
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

"Panel Sequencing for Targeted Therapy Selection in Solid TumorsMolecular Diagnostic Testing for Hematopoietic Neoplasms: Linking Pathogenic Drivers to Personalized DiagnosisSpecial Considerations in the Molecular Diagnostics of Pediatric NeoplasmsSpecimen Considerations in Molecular Oncology TestingUtility of Single-Gene Testing in Cancer SpecimensAnalytical Principles of Cancer Next Generation SequencingPrinciples and Validation of Bioinformatics Pipeline for Cancer Next-Generation SequencingBest Practice for Clinical Somatic Variant Interpretation and ReportingMolecular Detection of Oncogenic Gene RearrangementsCopy Number Analysis in Cancer Diagnostic TestingMolecular Biomarkers of Response to Cancer ImmunotherapyWhen Tissue Is the Issue: Expanding Cell-Free DNA ""Liquid Biopsies to Supernatants and Nonplasma BiofluidsGermline Testing for the Evaluation of Hereditary Cancer Predisposition"